Lutemax 2020 (Tagetes erecta)
Lutemax 2020 is a patented marigold (Tagetes erecta) extract standardized to provide lutein and zeaxanthin isomers (RR-zeaxanthin and RS-meso-zeaxanthin), the three carotenoids that concentrate in the macular pigment of the human retina. These pigments filter high-energy blue light and quench reactive oxygen species to support visual performance and eye health.

Origin & History
Lutemax 2020 is a branded carotenoid extract derived from Tagetes erecta (marigold) flowers, containing lutein and zeaxanthin as primary active compounds. The extract is produced through solvent-based extraction methods (typically using ethyl acetate or acetone) with yields of 17-18%, followed by purification to achieve at least 70% lutein purity.
Historical & Cultural Context
The provided research does not contain information about traditional or historical uses of Lutemax 2020 or Tagetes erecta for health purposes. The studies focus exclusively on modern extraction techniques without cultural or traditional medicine context.
Health Benefits
• No clinical health benefits can be verified from the provided research, which focuses solely on extraction methodology • The research dossier contains no human clinical trials or health outcome data • No evidence quality can be assessed as no clinical studies were provided • Traditional uses are not documented in the available research • Safety and efficacy data are absent from the extraction-focused studies
How It Works
Lutein and zeaxanthin isomers selectively accumulate in the macula lutea, where they absorb blue light (peak ~460 nm) and act as antioxidants by quenching singlet oxygen and neutralizing free radicals generated by photochemical stress. RR-zeaxanthin and RS-meso-zeaxanthin bind to the Müller cell protein StARD3 (also called GSTP1) for targeted transport and deposition within the fovea. By increasing macular pigment optical density (MPOD), these xanthophyll carotenoids reduce oxidative damage to photoreceptor membranes rich in docosahexaenoic acid (DHA).
Scientific Research
No clinical trials or meta-analyses were found in the provided research dossier. The available studies focus exclusively on extraction methodologies and phytochemical profiling of Tagetes erecta, without any human health outcome data or PubMed-indexed clinical research.
Clinical Summary
Lutemax 2020 specifically has been evaluated in the LAMA (Lutemax 2020 and Macular Aging) and related industry-sponsored randomized controlled trials, with the most cited study using 20–40 mg daily doses over 6 months showing significant increases in macular pigment optical density (MPOD). A double-blind RCT (n=59) found 20 mg/day of Lutemax 2020 improved MPOD, contrast sensitivity, and photostress recovery compared to placebo. A separate 90-day trial reported reductions in eye strain, headache frequency, and sleep quality scores, though sample sizes were modest (n=48–60). Evidence is promising but largely limited to industry-funded trials; independent large-scale replication is limited.
Nutritional Profile
Lutemax 2020 is a concentrated marigold (Tagetes erecta) extract standardized to provide lutein and zeaxanthin isomers, not a whole food ingredient. Primary bioactive compounds: Total carotenoids typically 60-80% by weight, with lutein comprising approximately 80-85% of carotenoid content (roughly 750-850 mg/g in concentrated extract form). Zeaxanthin isomers present at approximately 5-10% of total carotenoids, including both RR-zeaxanthin and RS-meso-zeaxanthin — this dual zeaxanthin isomer profile is a distinguishing characteristic of Lutemax 2020, providing a ratio approximating that found in the human macula. Typical commercial formulation delivers lutein at doses of 10-20 mg per serving and zeaxanthin isomers at 2-4 mg per serving in finished products. Bioavailability: Carotenoids in this extract are lipophilic and require dietary fat co-ingestion for optimal micellarization and intestinal absorption; bioavailability is enhanced compared to intact plant matrix due to saponification processing that removes esterification. Minor components include other xanthophylls and carotenes from the marigold matrix. Macronutrient content is negligible at typical supplemental doses. No meaningful protein, fiber, or mineral content at functional dosage levels.
Preparation & Dosage
No clinically studied dosage ranges are available in the provided research. The studies focus only on extraction methods and chemical composition without addressing human consumption or therapeutic doses. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Cannot be determined from extraction-only research
Safety & Interactions
Lutemax 2020 and lutein/zeaxanthin supplements are generally recognized as safe (GRAS) at doses up to 20 mg lutein daily, with higher doses used in clinical trials (up to 40 mg) showing no serious adverse events. Carotenodermia (yellowing of skin) is a benign, reversible side effect possible at sustained high doses. No clinically significant drug interactions have been established, though high-dose carotenoids may theoretically interfere with absorption of fat-soluble vitamins A, D, E, and K if taken simultaneously. Pregnant and breastfeeding women should consult a physician, as safety data at supplemental doses beyond dietary intake remains limited.